KP136 is a specialty chemical primarily used in pharmaceutical research and development, particularly for cancer treatment. It possesses properties that inhibit the growth of cancer cells and may help reduce their metastasis within the body. Additionally, ongoing studies explore its potential as an antioxidant, which could prevent cellular damage from oxidative processes. As a key intermediate in organic synthesis, KP136 also finds applications in developing active pharmaceutical ingredients (APIs) for therapeutic drugs. It is currently in the research stage but is expected to play a significant role in future medical treatments and disease management, with versatility extending to academic and industrial settings.